This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Adamis Pharmaceuticals Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Charles Peter Lollo
Introduction
Charles Peter Lollo is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on the intersection of biochemistry and medicine, aiming to improve treatment methods for various diseases.
Latest Patents
Lollo holds a patent for a formulation that includes a combination of beta-endorphin and adrenocorticotropic hormone (ACTH). This patent outlines compositions that are useful in methods of treating disease. The innovative approach taken in this formulation highlights Lollo's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Lollo has been associated with Adamis Pharmaceuticals Corporation, where he has played a pivotal role in research and development. His expertise in pharmaceutical formulations has contributed to the company's mission of delivering effective therapeutic solutions.
Collaborations
Lollo has worked alongside notable professionals in the industry, including his coworker Dennis J Carlo. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.
Conclusion
Charles Peter Lollo's contributions to the field of pharmaceuticals through his innovative formulations and collaborations exemplify his dedication to improving healthcare. His work continues to inspire future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile